[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@Redeye_](/creator/twitter/Redeye_) "Redeye updates its estimates and valuation after Indutrades Q2 2025 report. $INDT" [X Link](https://x.com/Redeye_/status/1945349912696156366) [@Redeye_](/creator/x/Redeye_) 2025-07-16T05:08Z 14.5K followers, 1291 engagements "Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO" [X Link](https://x.com/Redeye_/status/1955189857602469971) [@Redeye_](/creator/x/Redeye_) 2025-08-12T08:49Z 14.5K followers, 1010 engagements "Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO" [X Link](https://x.com/Redeye_/status/1955529686043501021) [@Redeye_](/creator/x/Redeye_) 2025-08-13T07:19Z 14.5K followers, 1140 engagements "Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO" [X Link](https://x.com/Redeye_/status/1940346251234640071) [@Redeye_](/creator/x/Redeye_) 2025-07-02T09:46Z 14.5K followers, 1449 engagements "Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR" [X Link](https://x.com/Redeye_/status/1961072328944636250) [@Redeye_](/creator/x/Redeye_) 2025-08-28T14:24Z 14.5K followers, 1215 engagements "Redeye comments on Verve's announced acquisition. $VER" [X Link](https://x.com/Redeye_/status/1968331752470097950) [@Redeye_](/creator/x/Redeye_) 2025-09-17T15:10Z 14.5K followers, 1335 engagements "Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER" [X Link](https://x.com/Redeye_/status/1970009407556649224) [@Redeye_](/creator/x/Redeye_) 2025-09-22T06:16Z 14.5K followers, 1416 engagements "BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO" [X Link](https://x.com/Redeye_/status/1975477431659340000) [@Redeye_](/creator/x/Redeye_) 2025-10-07T08:24Z 14.5K followers, 1156 engagements "Redeye provides a comment on the Q3 trading update from Cheffelo released this morning. $CHEF" [X Link](https://x.com/Redeye_/status/1976552806464049309) [@Redeye_](/creator/x/Redeye_) 2025-10-10T07:38Z 14.5K followers, 1234 engagements "Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE" [X Link](https://x.com/Redeye_/status/1978381140831457496) [@Redeye_](/creator/x/Redeye_) 2025-10-15T08:43Z 14.5K followers, XXX engagements "Redeye provides its initial take on Vitecs Q3 2025 report which came in broadly below our estimates. $VIT" [X Link](https://x.com/Redeye_/status/1978738525576024436) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:23Z 14.5K followers, XXX engagements "Redeye shares its preview of BONESUPPORTs Q3 2025 results due October XX. $BONEX" [X Link](https://x.com/Redeye_/status/1978738980804825380) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:25Z 14.5K followers, 1036 engagements "Redeye updates its estimates and valuation after Vitecs Q3 2025 report. $VIT" [X Link](https://x.com/Redeye_/status/1979058100423291260) [@Redeye_](/creator/x/Redeye_) 2025-10-17T05:33Z 14.5K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Redeye_
"Redeye updates its estimates and valuation after Indutrades Q2 2025 report. $INDT"
X Link @Redeye_ 2025-07-16T05:08Z 14.5K followers, 1291 engagements
"Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO"
X Link @Redeye_ 2025-08-12T08:49Z 14.5K followers, 1010 engagements
"Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO"
X Link @Redeye_ 2025-08-13T07:19Z 14.5K followers, 1140 engagements
"Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO"
X Link @Redeye_ 2025-07-02T09:46Z 14.5K followers, 1449 engagements
"Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR"
X Link @Redeye_ 2025-08-28T14:24Z 14.5K followers, 1215 engagements
"Redeye comments on Verve's announced acquisition. $VER"
X Link @Redeye_ 2025-09-17T15:10Z 14.5K followers, 1335 engagements
"Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER"
X Link @Redeye_ 2025-09-22T06:16Z 14.5K followers, 1416 engagements
"BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO"
X Link @Redeye_ 2025-10-07T08:24Z 14.5K followers, 1156 engagements
"Redeye provides a comment on the Q3 trading update from Cheffelo released this morning. $CHEF"
X Link @Redeye_ 2025-10-10T07:38Z 14.5K followers, 1234 engagements
"Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE"
X Link @Redeye_ 2025-10-15T08:43Z 14.5K followers, XXX engagements
"Redeye provides its initial take on Vitecs Q3 2025 report which came in broadly below our estimates. $VIT"
X Link @Redeye_ 2025-10-16T08:23Z 14.5K followers, XXX engagements
"Redeye shares its preview of BONESUPPORTs Q3 2025 results due October XX. $BONEX"
X Link @Redeye_ 2025-10-16T08:25Z 14.5K followers, 1036 engagements
"Redeye updates its estimates and valuation after Vitecs Q3 2025 report. $VIT"
X Link @Redeye_ 2025-10-17T05:33Z 14.5K followers, XXX engagements
/creator/twitter::153838561/posts